High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census

Published:2014-07-07 Issue:2 Volume:35 Page:542-549
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Fung James¹²³,Lee Cheuk-Kwong⁴,Chan Monica⁵,Seto Wai-Kay¹²³,Lai Ching-Lung¹²,Yuen Man-Fung¹²³,

Affiliation:

1. Departrment of Medicine; Queen Mary Hospital; The University of Hong Kong; Hong Kong China

2. State Key Laboratory for Liver Research; The University of Hong Kong; Hong Kong China

3. Hong Kong Liver Foundation; Hong Kong China

4. Hong Kong Red Cross Blood Transfusion Service; Hong Kong China

5. Access Medical Diagnostics and Laboratory Centre; Hong Kong China

Funder

GlaxoSmithKline

Novartis Pharmaceuticals

Bristol-Myers-Squibbs

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12619/fullpdf

Reference28 articles.

1. GI epidemiology: nonalcoholic fatty liver disease;Angulo;Aliment Pharmacol Ther,2007

2. Global challenges in liver disease;Williams;Hepatology,2006

3. Nonalcoholic fatty liver disease: from steatosis to cirrhosis;Farrell;Hepatology,2006

4. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis;Ascha;Hepatology,2010

5. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?;Fan;J Gastroenterol Hepatol,2007

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial;Hepatology;2024-03-27

2. Impact of hepatic steatosis on risk of acute liver injury in people with chronic hepatitis B and SARS‐CoV‐2 infection;Liver International Communications;2024-03

3. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study;Annals of Hepatology;2024-01

4. High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter;BMC Gastroenterology;2023-09-12

5. COVID-19 and Fatty Liver Disorders;Journal of Clinical Medicine;2023-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3